Figure 3. Resveratrol alleviates the effect of bleomycin on BEAS-2B cells. (A) The cell viability of BEAS-2B cells after different treatments (n = 6 in each group). (B) The expression of Cyclin D1 and Cyclin D3 in different groups (n = 6 in each group). (C) The level of HIF-1α in different groups at each postoperative time point (n = 6 in each group). (D) The expression of NF-κB in different groups at each postoperative time point (n = 6 in each group). *p < 0.05, **p < 0.01, ***p < 0.001, ***p < 0.0001.